ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

152 Épisodes

1. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Myocarditis

   Publié: 21/06/2022
2. ACCEL Lite: Inflamed! Populations at Risk for Inflammation Associated CVD

   Publié: 14/06/2022
3. ACCEL Lite: Significant Updates from the 2021 ACC Coronary Artery Revascularization Guidelines

   Publié: 07/06/2022
4. ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR

   Publié: 24/05/2022
5. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

   Publié: 17/05/2022
6. ACCEL Lite: ACC.22 Late Breaker: CHAP RCT -- Antihypertensive Therapy For Mild Chronic Hypertension Improves Pregnancy Outcomes

   Publié: 10/05/2022
7. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

   Publié: 03/05/2022
8. ACCEL Lite: Late Breaker: Mavacamten as an Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

   Publié: 26/04/2022
9. ACCEL Lite: Late Breaker: SODIUM-HF: Dietary Intervention Under 100 Mmol In Heart Failure

   Publié: 19/04/2022
10. ACCEL Lite: Late Breaker: METEORIC-HF: The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic HFrEF

    Publié: 12/04/2022
11. ACCEL Lite: Late Breaker: DIAMOND trial: Patiromer For The Management Of Hyperkalemia In Subjects Receiving Renin-angiotensin-aldosterone System Inhibitor Medications For HFrEF

    Publié: 05/04/2022
12. ACCEL Lite: Screening for Transthretin Amyloid Cardiomyopathy in Everyday Practice

    Publié: 22/03/2022
13. ACCEL Lite: When Is Genetic Testing Helpful?

    Publié: 15/03/2022
14. ACCEL Lite: Special Considerations in Screening of Masters Athletes with CAD

    Publié: 08/03/2022
15. ACCEL Lite: Helping Patients Improve Lifestyle Behavior in the Digital Era

    Publié: 01/03/2022
16. ACCEL Lite: Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis--Focus on AL

    Publié: 22/02/2022
17. ACCEL Lite: What Should Optimal Medical Therapy Look Like Prior to Intervention?

    Publié: 15/02/2022
18. ACCEL Lite: Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL-Cholesterol

    Publié: 08/02/2022
19. ACCEL Lite: Debate: Atrial Fibrillation Management in Athletes

    Publié: 01/02/2022
20. ACCEL Lite: Associations of Cardiac Mechanics with Exercise Capacity: The Multi-Ethnic Study of Atherosclerosis

    Publié: 25/01/2022